ATE341564T1 - Anti-idiotypische monoklonale antikörper, deren verwendung zur aktiven immuntherapie bösartiger tumoren, und zusammensetzungen die diese enthalten - Google Patents

Anti-idiotypische monoklonale antikörper, deren verwendung zur aktiven immuntherapie bösartiger tumoren, und zusammensetzungen die diese enthalten

Info

Publication number
ATE341564T1
ATE341564T1 AT98952503T AT98952503T ATE341564T1 AT E341564 T1 ATE341564 T1 AT E341564T1 AT 98952503 T AT98952503 T AT 98952503T AT 98952503 T AT98952503 T AT 98952503T AT E341564 T1 ATE341564 T1 AT E341564T1
Authority
AT
Austria
Prior art keywords
monoclonal antibodies
compositions containing
malignant tumors
containing same
active immunotherapy
Prior art date
Application number
AT98952503T
Other languages
English (en)
Inventor
Lopez Ana Maria Vasquez
Rodriguez Rolando Perez
Sierra Eladio Iglesias
Gonzalez Alexis Perez
Lopez Gumersinda Bombino
Delgado Irene Beausoleil
Original Assignee
Centro Inmunologia Molecular
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro Inmunologia Molecular filed Critical Centro Inmunologia Molecular
Application granted granted Critical
Publication of ATE341564T1 publication Critical patent/ATE341564T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • C07K16/4266—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT98952503T 1997-10-21 1998-10-21 Anti-idiotypische monoklonale antikörper, deren verwendung zur aktiven immuntherapie bösartiger tumoren, und zusammensetzungen die diese enthalten ATE341564T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU1997119A CU22702A1 (es) 1997-10-21 1997-10-21 Anticuerpos monoclonales anti - idiotipo, su uso en la inmunoterapia activa de tumores malignos, hibridoma que los produce y composiciones que los contienen

Publications (1)

Publication Number Publication Date
ATE341564T1 true ATE341564T1 (de) 2006-10-15

Family

ID=5459399

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98952503T ATE341564T1 (de) 1997-10-21 1998-10-21 Anti-idiotypische monoklonale antikörper, deren verwendung zur aktiven immuntherapie bösartiger tumoren, und zusammensetzungen die diese enthalten

Country Status (19)

Country Link
EP (1) EP1027375B1 (de)
JP (1) JP4304287B2 (de)
KR (1) KR100567209B1 (de)
CN (1) CN1210309C (de)
AR (1) AR017369A1 (de)
AT (1) ATE341564T1 (de)
AU (1) AU1019999A (de)
BR (1) BR9812974A (de)
CA (1) CA2308142C (de)
CO (1) CO5060487A1 (de)
CU (1) CU22702A1 (de)
CY (1) CY1105844T1 (de)
DE (1) DE69836096T2 (de)
DK (1) DK1027375T3 (de)
EA (1) EA003366B1 (de)
ES (1) ES2274584T3 (de)
PT (1) PT1027375E (de)
SI (1) SI1027375T1 (de)
WO (1) WO1999020656A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23007A1 (es) * 2001-04-06 2004-12-17 Ct De Inmunologia Molecular Ct De Inmunologia Mole Combinaciones inmunoterapéuticas para el tratamiencombinaciones inmunoterapéuticas para el tratamiento de tumores que sobre-expresan gangliósidos to de tumores que sobre-expresan gangliósidos
WO2011051466A1 (en) * 2009-11-02 2011-05-05 Novartis Ag Anti-idiotypic fibronectin-based binding molecules and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010221A1 (en) * 1991-11-13 1993-05-27 The Regents Of The University Of California Chimeric murine/human anti-idiotype monoclonal antibodies
US5653977A (en) * 1993-09-09 1997-08-05 Uab Research Foundation Anti-idiotypic antibody that mimics the GD2 antigen
DE69428763T2 (de) * 1993-12-09 2002-08-01 Centro De Inmunologia Molecular, Ciudad De La Habana Monoklonale Antikörper gegen Ganglioside und deren Verwendung in der spezifischen, aktiven Immuntherapie gegen bösartige Tumoren
CU22420A1 (es) * 1993-12-29 1996-01-31 Centro Inmunologia Molecular Composicion vacunal para el desarrollo de una respuesta contra gangliosidos n glicolilados y su uso para el tratamiento del cancer
CU22585A1 (es) * 1995-11-17 1999-11-03 Centro Inmunologia Molecular Anticuerpos monoclonales antiidiótipos (ab2) de tipo igg con alta conectividad idiotípica y composiciones farmacéuticas que los contienen. su uso como inmunoreguladores de la respuesta inmune.
US5792455A (en) * 1996-03-21 1998-08-11 Sloan-Kettering Institute For Cancer Research Anti-idiotypic antibody vaccines

Also Published As

Publication number Publication date
BR9812974A (pt) 2000-08-08
WO1999020656A1 (es) 1999-04-29
EP1027375B1 (de) 2006-10-04
CN1279692A (zh) 2001-01-10
EA003366B1 (ru) 2003-04-24
SI1027375T1 (sl) 2007-02-28
CA2308142A1 (en) 1999-04-29
AR017369A1 (es) 2001-09-05
AU1019999A (en) 1999-05-10
CA2308142C (en) 2005-06-14
EA200000442A1 (ru) 2000-10-30
CN1210309C (zh) 2005-07-13
KR20010031283A (ko) 2001-04-16
JP2001520034A (ja) 2001-10-30
PT1027375E (pt) 2007-01-31
CY1105844T1 (el) 2011-02-02
HK1034264A1 (en) 2001-10-19
DE69836096D1 (de) 2006-11-16
KR100567209B1 (ko) 2006-04-03
CO5060487A1 (es) 2001-07-30
CU22702A1 (es) 2001-07-31
EP1027375A1 (de) 2000-08-16
DE69836096T2 (de) 2007-05-16
JP4304287B2 (ja) 2009-07-29
DK1027375T3 (da) 2007-02-05
ES2274584T3 (es) 2007-05-16

Similar Documents

Publication Publication Date Title
DE69831222D1 (de) Verbindungen zur immundiagnose von prostatakrebs und deren verwendung
DE59813875D1 (de) Ko-stimulierendes polypeptid von t-zellen, monoklonale antikörper sowie die herstellung und deren verwendung
NO994069D0 (no) Forbindelser for immunoterapi av prostatacancer og fremgangsmåte for anvendelse derav
EP1071458A4 (de) Humanisierter antikörper und dessen verwendungen
DE69927268D1 (de) Spezifische antikörper enthaltende bindungsproteine die das nekrotische tumorzentrum binden und deren verwendung
AU5414996A (en) Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma
DE69723398T2 (de) Polyalkylphenoxyaminoalkane und diese enthaltende freibstoffzusammensetzungen
IL128003A0 (en) Therapeutic multispecific compounds comprised of anti-fcalpha receptor antibodies
AU2010699A (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for theiruse
ITMI941928A0 (it) Procedimento per la fabbricazione di particelle di persali
AU6468998A (en) Compositions and method for the early diagnosis of ovarian cancer
DE69804659D1 (de) 21-hydro-6,19-oxidoprogesterone (21oh-60p) und deren verwendung als arzneimittel zur behandlung von glukokortikoidüberschuss
ID20137A (id) Turunan propanolamina, proses pembuatannya, sediaan farmasi yang mengandung senyawa ini, dan penggunannya
DE69428763D1 (de) Monoklonale Antikörper gegen Ganglioside und deren Verwendung in der spezifischen, aktiven Immuntherapie gegen bösartige Tumoren
CA2185112A1 (en) Humanized monoclonal antibodies against human interleukin-4
ATE341564T1 (de) Anti-idiotypische monoklonale antikörper, deren verwendung zur aktiven immuntherapie bösartiger tumoren, und zusammensetzungen die diese enthalten
AU9689398A (en) Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer
DE69809223D1 (de) 5-alpha-pregnan-3-beta-ol-20-one 3-sulfate für di behandlung von tumoren und zns krankheiten
DE69800080D1 (de) Antikörper gegen das Prorenin Profragment, reninaktive Substanz die diese enthält und Prorenintest die diese verwendet
HK1032238A (en) Anti-idiotypic monoclonal antibodies, their use in the active immunotherapy of malignant tumors, and compositions containing them
AU2003204088A1 (en) Anti-idiotypic monoclonal antibodies, their use in the active immunotherapy of malignant tumors, and compositions containing them
AU2003204129A1 (en) Anti-idiotype monoclonal antibodies, their use in active immunotherapy of malignant tumors and compositions containing them
IT1293510B1 (it) Anticorpi monoclonali catalitici per la trasformazione in vivo di profarmaci di corticosteroidi
ZA9811800B (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
DE69513005D1 (de) Platinkomplex und diese enthaltende Arzneimittel für die Behandlung von bösartigen Tumoren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1027375

Country of ref document: EP